City

Guangzhou (1)

Guiyang (1)

Hangzhou (1)

Hong Kong (1)

Condition

Advanced Nasopharyngeal Carcinoma (4)

Overall Status

Recruiting (2)

Completed (1)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Chinese University of Hong Kong (1)

Guiyang Medical University (1)

Shanghai Junshi Bioscience Co., Ltd. (1)

Zhejiang Cancer Hospital (1)

Collaborator

Intervention

chemotherapy (1)

gp+imrt (1)

sbrt (1)

toripalimab /js001 (1)

toripalimab injection(subcutaneous)/js001sc (1)

tpf+imrt (1)

Study Documents

Intervention Type

drug (2)

biological (1)

radiation (1)

Funder Type

Other (4)

Study Type

Interventional (2)

Observational (1)

Observational [Patient Registry] (1)

advanced nasopharyngeal carcinoma

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (Toripalimab injection(subcutaneous)/JS001sc, Toripalimab /JS001)

Recruiting

Advanced Nasopharyngeal Carcinoma

Toripalimab injection(subcutaneous)/JS001sc
Toripalimab /JS001

Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center

Feb 21, 2023

Advanced Nasopharyngeal Carcinoma Trial in Hangzhou (SBRT)

Recruiting

Advanced Nasopharyngeal Carcinoma

SBRT

Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital

Dec 5, 2022

Advanced Nasopharyngeal Carcinoma Trial in Guiyang (GP+IMRT, TPF+IMRT)

Unknown status

Advanced Nasopharyngeal Carcinoma

Guiyang, Guizhou, China

Cancer Hospital of Guizhou Medical University

Oct 26, 2018

Drug Response for Treatment of Nasopharyngeal Cancer

Completed

Advanced Nasopharyngeal Carcinoma

Chemotherapy

Hong Kong, Hong Kong

Department of Clinical Oncology, Prince of Wales Hospital

Mar 22, 2017